Compare NIO Inc. (NIO) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs TG Therapeutics Inc — how do they compare? NIO Inc. trades at $4.8 (market cap $12.55B), while TG Therapeutics Inc trades at $54.06 (market cap $8.26B). The key difference: NIO Inc. is the larger of the two by market cap, and TG Therapeutics Inc is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| NIO | TGTX | |
|---|---|---|
Market Cap | $12.55B | $8.26B |
Sector | Consumer Cyclical | Health |
52-Week High | $7.89 | $59.06 |
52-Week Low | $4.44 | $26.39 |
Enterprise Value | $11.78B | $8.50B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
